Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type

This publication has 14 references indexed in Scilit:

• Gastric MALT lymphoma: From concept to cure
  Annals of Oncology, 1999
• Additional Value of Whole-Body Positron Emission Tomography With Fluorine-18-2-Fluoro-2-deoxy-d-glucose in Recurrent Colorectal Cancer
  Journal of Clinical Oncology, 1999
• Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography
  European Journal of Nuclear Medicine and Molecular Imaging, 1998
• Detection of Unsuspected Recurrent Lymphoma With Fluorodeoxyglucose-Positron Emission Tomographic Imaging After Induction Chemotherapy
  American Journal of Clinical Oncology, 1998
• Cure of Helicobacter pylori Infection and Duration of Remission of Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
  JNCI Journal of the National Cancer Institute, 1997
• PET in oncology: Will it replace the other modalities?
  Seminars in Nuclear Medicine, 1997
• Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients.
  Journal of Clinical Oncology, 1997
• Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose
  European Journal of Nuclear Medicine and Molecular Imaging, 1996
• A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]
  Blood, 1994
• Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
  Radiology, 1994